With 2023 well underway, the crucial question for both bio/pharma companies and their suppliers is: how will the industry perform in 2023 and the near term?  

DCAT Week’s flagship program, Pharma Industry Outlook, will answer that question by providing you with need-to-know market intelligence on the current and projected performance of the bio/pharma industry. Graham Lewis, Vice President of Global Pharma Strategy, IQVIA, a business intelligence firm regarded as the gold standard for bio/pharmaceutical market analysis, will provide the latest market data and trends.  

Get answers to these all-important questions: 

• What are the growth prospects globally and in key geographic markets? 

• How is the industry faring in new drug development and what can be expected near term?  
• Where is the growth in small molecules, biologics, and new modalities such as cell and gene therapies? 

Small bio/pharmaceutical companies play an increasingly important role in product innovation for the industry, but what is the financial outlook for this sector? Get expert insight from Arda Ural, PhD, EY Americas Health Sciences and Wellness Industry Markets Leader, Ernst & Young (EY), on the key trends in industry deal-making and capital flow into Emerging Pharma, a vital customer base for CDMOs/CMOs and partner for bio/pharma companies.  

Pharma Industry Outlook will be held at the InterContinental Barclay Hotel, Grand Ballroom on Monday, March 20, 2023: 2:30 – 4:30 PM; Doors open at 2:00 PM for networking. Plus, Post-Program Attendee Networking Reception: 4:30 to 6:00 PM.  

Register or learn more about this program here. 

The full schedule for the other education programs at DCAT Week and networking events may be found here.